Toll-like receptor signaling plays an important role in the pathogenesis of inflammatory bowel disease (IBD)18; whereas IL-17 signaling is involved in the development of colonic tissue damage and inflammation during UC19. This evidence concerns the gene IL17A and inflammatory bowel disease.